We’re a global biotechnology company on a mission to discover, develop and deliver new treatments to improve the lives of people all over the world. That’s why we conduct clinical trials.
In fact, everyone who takes part in a trial contributes to our understanding of a particular disease and help others like them – not just in their community, but all around the world.
So far, we’ve conducted hundreds of trials, involving thousands of people.
But we couldn’t do any of this without our team. Currently, we employ over 9,000 people all over the world.* That’s 9,000 people who work fearlessly in the pursuit of innovation and care deeply about making a difference to people like you.
*As of 31 December 2020
**Projected number of enrolled participants on active studies. An active clinical trial is one with a recruitment status of Not Yet Recruiting, Recruiting, Enrolled by invitation, or Active Not Recruiting on clinicaltrials.gov. All figures displayed are calculated in realtime based on Biogen studies posted to clinicaltrials.gov.
We’re committed to the
power of diversity
Both in our organization and among our patients. Every day, we work toward making clinical trials and the healthcare system more fair and inclusive.
Diversity in clinical trials not only creates a more level playing field when it comes to the quality of healthcare that people receive; it can also lead to wider knowledge about diseases and potential treatments for everyone.
After all, each and every person who takes part in a trial provides unique and important information that helps us take steps toward developing a healthier world.
We’re pioneers in
neuroscience
Over the past decade, we’ve led scientific research with the goal of finding potential new treatments for neurological diseases that affect millions of people, around the world. Neuroscience, in particular, is a disease area with many unmet needs that stand to benefit from medical advancements.
Our scientific expertise, and our courage to take risks make us ideally placed to lead the development of treatments.
Our neurologists and neuroscientists engage with physicians and scientific leaders around the world, with the aim of furthering our research.
We respect the contributions of healthcare providers who care for people living with neurological diseases. We also honor the important role of their caregivers, families and friends.
We’re committed to working with advocacy groups and patient organizations who serve the communities they represent.
